20.01.2016 • NewsCatalysis & CatalystsCambridgeChemistry

Johnson Matthey Expands R&D and Scale-up Facilities in Cambridge, UK

Johnson Matthey’s Fine Chemicals Division has completed an expansion of its Cambridge, UK facilities, bringing additional process research & development services and kilo-scale manufacture to the growing site. This investment supports the use of the company’s catalyst and biocatalyst technology in process R&D and non-GMP production of materials for pre-clinical pharmaceutical and toxicology studies.

The expansion will accommodate teams of chemistry and biocatalysis process R&D scientists who will provide route scouting, process development, optimisation and scale-up of heterogeneous, homogeneous and biocatalytic processes, as well as the non-GMP kilo-scale manufacture of APIs and intermediates.

“The completion of this investment follows our recent acquisition of pharmaceutical manufacturing capacity in Annan, Scotland and the Pharmorphix solid form sciences business based in Cambridge, UK,” said John Fowler, Division Director at Johnson Matthey Fine Chemicals. “It further supports our expanding global pharma services offering to enable our customers with the rapid development and sustainable manufacture of pharmaceuticals.”

The expanded facility includes 20 fume cupboards, two new kilo labs with capacity up to 100 L, a 20 L Hastelloy pressure vessel (operating to 50 bar) and fermenters for enzyme production.
 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.